Literature DB >> 21718168

Culturing bovine nucleus pulposus explants by balancing medium osmolarity.

Bart van Dijk1, Esther Potier, Keita Ito.   

Abstract

Regenerative therapies are promising treatments for early intervertebral disc degeneration. To test their efficacy, an in vitro tissue-level model would be valuable. Nucleus pulposus (NP) explant culture may constitute such a model, as the earliest signs of degeneration are in the NP. However, in NP explant cultures, balancing tissue osmolarity is crucial to preventing swelling, proteoglycan (PG) loss and, therefore, maintaining a native cell environment. In this study, we investigated the effect of medium osmolarity on NP explants. We hypothesized that balancing the inherent tissue osmolarity would prevent swelling and thus maintain NP tissue in a native state. Bovine NP explants were cultured for 21 days in hypo-, iso-, and hyper-tonic conditions using either sucrose or polyethylene glycol (PEG) to raise medium osmolarity. Explants were analyzed for water and biochemical content, cell viability, gene expression, and tissue histology, and compared to day 0 samples. In hypo-tonic and both sucrose cultures, swelling was not prevented, resulting in PG loss and changes in cell behavior. Only PEG cultures maintained water and biochemical content and a histological aspect similar to those of native tissue, with better results for hyper- than for iso-tonic conditions. Using PEG to raise culture medium osmolarity, we were able to maintain the NP tissue specific matrix composition, important for disc cell behavior. This approach, thus, constitutes a promising model to test regenerative therapies for early intervertebral disc degeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718168     DOI: 10.1089/ten.TEC.2011.0215

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  27 in total

1.  Using notochordal cells of developmental origin to stimulate nucleus pulposus cells and bone marrow stromal cells for intervertebral disc regeneration.

Authors:  Esther Potier; Keita Ito
Journal:  Eur Spine J       Date:  2013-11-21       Impact factor: 3.134

2.  Analyzing the effects of mechanical and osmotic loading on glycosaminoglycan synthesis rate in cartilaginous tissues.

Authors:  Xin Gao; Qiaoqiao Zhu; Weiyong Gu
Journal:  J Biomech       Date:  2015-01-21       Impact factor: 2.712

3.  Can notochordal cells promote bone marrow stromal cell potential for nucleus pulposus enrichment? A simplified in vitro system.

Authors:  Esther Potier; Keita Ito
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

Review 4.  Understanding nucleus pulposus cell phenotype: a prerequisite for stem cell based therapies to treat intervertebral disc degeneration.

Authors:  Hyowon Choi; Zariel I Johnson; Makarand V Risbud
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

5.  Simulation of biological therapies for degenerated intervertebral discs.

Authors:  Qiaoqiao Zhu; Xin Gao; H Thomas Temple; Mark D Brown; Weiyong Gu
Journal:  J Orthop Res       Date:  2015-10-13       Impact factor: 3.494

Review 6.  Glycosaminoglycan synthesis in the nucleus pulposus: Dysregulation and the pathogenesis of disc degeneration.

Authors:  Elizabeth S Silagi; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2018-03-01       Impact factor: 11.583

Review 7.  Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration.

Authors:  Yizhong Peng; Xiangcheng Qing; Hongyang Shu; Shuo Tian; Wenbo Yang; Songfeng Chen; Hui Lin; Xiao Lv; Lei Zhao; Xi Chen; Feifei Pu; Donghua Huang; Xu Cao; Zengwu Shao
Journal:  Biomater Transl       Date:  2021-06-28

Review 8.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

9.  Arp2/3 inactivation causes intervertebral disc and cartilage degeneration with dysregulated TonEBP-mediated osmoadaptation.

Authors:  Steven Tessier; Alexandra C Doolittle; Kimheak Sao; Jeremy D Rotty; James E Bear; Veronica Ulici; Richard F Loeser; Irving M Shapiro; Brian O Diekman; Makarand V Risbud
Journal:  JCI Insight       Date:  2020-02-27

Review 10.  Potential regenerative treatment strategies for intervertebral disc degeneration in dogs.

Authors:  Frances C Bach; Nicole Willems; Louis C Penning; Keita Ito; Björn P Meij; Marianna A Tryfonidou
Journal:  BMC Vet Res       Date:  2014-01-04       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.